Although it is known that Mstn inhibits PGC-1α and thus Fndc5 expression by activating p-Smad3 (Dong et al., 2016), the interaction between these two myokines in the pathogenesis of skeletal muscle dysfunction in COPD has not been reported. Here, FNDC5 is linked to chronic obstructive pulmonary disease.